Literature DB >> 9298723

Human immunodeficiency virus (HIV)-related pulmonary complications in pregnancy.

G R Saade1.   

Abstract

With changes in the demographics of human immunodeficiency virus (HIV) infection, women and children are becoming the fastest growing group of newly infected patients. With longer survival after HIV infection, more women infected with HIV are becoming pregnant. Pulmonary disease is one of the most common presenting conditions in an AIDS-defining illness. Pneumocystis carini pneumonia and tuberculosis are the most common disorders that herald the onset of AIDS. They are also the most frequently encountered HIV-related pulmonary complications during pregnancy. Others have been rarely reported during pregnancy and include fungal infections (Cryptococcus neoformans, Histoplasma capsulatum, and Coccidioides immitus), bacterial infections (Haemophilus influenzae and Streptococcus pneumoniae along with Pseudomona aeruginosa), viral infections (CMV), opportunistic neoplasms (Kaposi's sarcoma, lymphoma) and miscellaneous conditions peculiar to HIV-infected individuals (nonspecific interstitial pneumonitis, lymphoid interstitial pneumonitis, isolated pulmonary hypertension, and pulmonary edema secondary to cardiac disease or drug abuse). Most of the data regarding the pulmonary complications of HIV infection come from studies in nonpregnant patients. The extent to which pregnancy affects the course of respiratory disease in HIV infection and vice versa is not well documented. Clinical presentation is usually not altered by pregnancy. Except for minor modifications mainly related to potential fetal effects, the diagnostic work-up and management are similar to those in the nonpregnant patient. The most important effect of pregnancy on these conditions remains the delay in diagnosis and treatment. A high index of suspicion should, therefore, be maintained. In addition, most prophylactic measures recommended in nonpregnant HIV-infected individuals also apply to pregnant women.

Entities:  

Mesh:

Year:  1997        PMID: 9298723     DOI: 10.1016/s0146-0005(97)80077-8

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  5 in total

Review 1.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

2.  Symptom screen: diagnostic usefulness in detecting pulmonary tuberculosis in HIV-infected pregnant women in Kenya.

Authors:  R J Kosgei; P M Ndavi; J O Ong'ech; J M Abuya; A M Siika; K Wools-Kaloustian; H Mabeya; T Fojo; A Mwangi; T Reid; M E Edginton; E J Carter
Journal:  Public Health Action       Date:  2011-10-26

3.  Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.

Authors:  Katelyn A Pastick; Elizabeth Nalintya; Lillian Tugume; Kenneth Ssebambulidde; Nicole Stephens; Emily E Evans; Jane Frances Ndyetukira; Edwin Nuwagira; Caleb Skipper; Conrad Muzoora; David B Meya; Joshua Rhein; David R Boulware; Radha Rajasingham
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

Review 4.  Use of antifungal drugs in pregnancy: a focus on safety.

Authors:  J D Sobel
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 5.  Treatment of community-acquired lower respiratory tract infections during pregnancy.

Authors:  Wei Shen Lim; John T Macfarlane; Charlotte L Colthorpe
Journal:  Am J Respir Med       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.